Correlation Between Inhibikase Therapeutics and Enzolytics
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Enzolytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Enzolytics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Enzolytics, you can compare the effects of market volatilities on Inhibikase Therapeutics and Enzolytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Enzolytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Enzolytics.
Diversification Opportunities for Inhibikase Therapeutics and Enzolytics
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inhibikase and Enzolytics is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Enzolytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzolytics and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Enzolytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzolytics has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Enzolytics go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Enzolytics
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 0.69 times more return on investment than Enzolytics. However, Inhibikase Therapeutics is 1.46 times less risky than Enzolytics. It trades about 0.07 of its potential returns per unit of risk. Enzolytics is currently generating about -0.06 per unit of risk. If you would invest 103.00 in Inhibikase Therapeutics on November 28, 2024 and sell it today you would earn a total of 121.00 from holding Inhibikase Therapeutics or generate 117.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.69% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Enzolytics
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Enzolytics |
Inhibikase Therapeutics and Enzolytics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Enzolytics
The main advantage of trading using opposite Inhibikase Therapeutics and Enzolytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Enzolytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzolytics will offset losses from the drop in Enzolytics' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Enzolytics vs. Creative Medical Technology | Enzolytics vs. Regen BioPharma | Enzolytics vs. Therasense | Enzolytics vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |